United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $776,550,129.77
- Nov. 21, 2024
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 11, 2014 | COO | 10,000 | $93.06 | Sell | $930,600.00 | |
July 10, 2014 | CEO | 9,187 | $92.33 | Sell | $848,235.71 | |
July 3, 2014 | Director | 1,500 | $91.62 | Sell | $137,430.00 | |
July 3, 2014 | CFO | 10,000 | $90.58 | Sell | $905,800.00 | |
July 3, 2014 | CEO | 3,833 | $91.37 | Sell | $350,221.21 | |
June 26, 2014 | CEO | 3,833 | $87.23 | Sell | $334,352.59 | |
June 20, 2014 | COO | 10,000 | $87.00 | Sell | $870,000.00 | |
June 19, 2014 | CEO | 3,833 | $85.68 | Sell | $328,411.44 | |
June 19, 2014 | EVP | 2,000 | $85.67 | Sell | $171,340.00 | |
June 19, 2014 | CFO | 10,000 | $87.02 | Sell | $870,200.00 | |
June 12, 2014 | CEO | 9,066 | $98.22 | Sell | $890,462.52 | |
June 10, 2014 | COO | 10,000 | $96.29 | Sell | $962,900.00 | |
June 9, 2014 | COO | 10,000 | $96.32 | Sell | $963,200.00 | |
June 5, 2014 | Director | 1,500 | $96.48 | Sell | $144,720.00 | |
June 5, 2014 | EVP | 6,000 | $96.50 | Sell | $579,000.00 | |
June 5, 2014 | CEO | 9,066 | $96.46 | Sell | $874,506.36 | |
June 3, 2014 | COO | 10,000 | $95.00 | Sell | $950,000.00 | |
May 29, 2014 | CEO | 9,066 | $95.27 | Sell | $863,717.82 | |
May 27, 2014 | COO | 10,000 | $99.14 | Sell | $991,400.00 | |
May 22, 2014 | Director | 30,000 | $101.46 | Sell | $3,043,800.00 | |
May 22, 2014 | CEO | 9,066 | $101.35 | Sell | $918,839.10 | |
May 20, 2014 | COO | 10,000 | $99.91 | Sell | $999,100.00 | |
May 16, 2014 | COO | 10,000 | $100.00 | Sell | $1,000,000.00 | |
May 15, 2014 | EVP | 6,000 | $100.86 | Sell | $605,160.00 | |
May 15, 2014 | CFO | 10,000 | $101.49 | Sell | $1,014,900.00 | |
May 15, 2014 | CEO | 9,066 | $100.88 | Sell | $914,578.08 | |
May 13, 2014 | COO | 10,000 | $105.53 | Sell | $1,055,300.00 | |
May 8, 2014 | CEO | 9,066 | $107.83 | Sell | $977,586.78 | |
May 8, 2014 | Director | 5,000 | $107.17 | Sell | $535,850.00 | |
May 6, 2014 | COO | 10,000 | $106.50 | Sell | $1,065,000.00 | |
May 2, 2014 | COO | 10,000 | $102.00 | Sell | $1,020,000.00 | |
May 1, 2014 | EVP | 6,000 | $102.71 | Sell | $616,260.00 | |
May 1, 2014 | CEO | 9,066 | $101.84 | Sell | $923,281.44 | |
May 1, 2014 | Director | 1,500 | $99.30 | Sell | $148,950.00 | |
May 1, 2014 | CFO | 10,000 | $102.20 | Sell | $1,022,000.00 | |
April 29, 2014 | COO | 10,000 | $95.00 | Sell | $950,000.00 | |
April 24, 2014 | CEO | 9,066 | $92.45 | Sell | $838,151.70 | |
April 22, 2014 | COO | 10,000 | $96.00 | Sell | $960,000.00 | |
April 17, 2014 | CFO | 10,000 | $96.20 | Sell | $962,000.00 | |
April 17, 2014 | EVP | 6,000 | $98.37 | Sell | $590,220.00 | |
April 17, 2014 | CEO | 9,066 | $98.48 | Sell | $892,819.68 | |
April 15, 2014 | COO | 10,000 | $95.06 | Sell | $950,600.00 | |
April 10, 2014 | CEO | 9,066 | $96.18 | Sell | $871,967.88 | |
April 8, 2014 | COO | 10,000 | $95.00 | Sell | $950,000.00 | |
April 4, 2014 | COO | 10,000 | $93.22 | Sell | $932,200.00 | |
April 3, 2014 | EVP | 6,000 | $93.10 | Sell | $558,600.00 | |
April 3, 2014 | CFO | 10,000 | $93.22 | Sell | $932,200.00 | |
April 3, 2014 | CEO | 9,066 | $93.74 | Sell | $849,846.84 | |
April 3, 2014 | Director | 1,500 | $95.67 | Sell | $143,505.00 | |
April 1, 2014 | COO | 10,000 | $95.44 | Sell | $954,400.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, DWEK RAYMOND, and MAHON PAUL A
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Nov. 21, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.